Author:
Charoo Naseem A.,Shamsher Areeg A.A.,Lian Lai Y.,Abrahamsson Bertil,Cristofoletti Rodrigo,Groot D.W.,Kopp Sabine,Langguth Peter,Polli James,Shah Vinod P.,Dressman Jennifer
Reference72 articles.
1. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Verapamil hydrochloride, propranolol hydrochloride, and atenolol;Vogelpoel;J Pharm Sci,2004
2. An application to recommend that beta-blockers be added to the WHO Model List of Essential Medicines for heart failure (12.4) and that the representative of the beta-blocker class be switched to bisoprolol from atenolol;Sandeep;Accessed November 10, 2012,,2011
3. World Health Organization (WHO),2006
4. United States Pharmacopoeia and National Formulary (USP 36-NF 31). 2013;The United States Pharmacopoeial Convention, Inc., 12601 Twinbrook Parkway, Rockville, Maryland 20852,2013
5. Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure;Konishi;Circulation J,2010
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献